Erratum: The changing epidemiology of malaria elimination: new strategies for new challenges (The Lancet (2013) 382(9895) (900–911) (S0140673613603104) (10.1016/S0140-6736(13)60310-4));The changing epidemiology of malaria elimination: New strategies for new challenges

The Lancet

Volumn 382, Issue 9895, 2013, Pages 900-911

  Cotter, Chris ^a   Sturrock, Hugh J W ^a   Hsiang, Michelle S ^a,b   Liu, Jenny ^a   Phillips, Allison A ^a   Hwang, Jimee ^a,c   Gueye, Cara Smith ^a   Fullman, Nancy ^a   Gosling, Roly D ^a   Feachem, Richard G A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ARTEMISININ; ICARIDIN; INSECTICIDE; MALARIA VACCINE; PRIMAQUINE;

AFRICA SOUTH OF THE SAHARA; DISEASE CLEARANCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INFECTION; INFECTION RISK; MALARIA; MALARIA CONTROL; MASS IMMUNIZATION; MIGRATION; NONHUMAN; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; REVIEW; SOCIAL BEHAVIOR; VECTOR CONTROL;

EID: 84883558894     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60894-6     Document Type: Erratum

References (145)

1. WHO. World malaria report 2011. Geneva: World Health Organization, 2011.
2. Pigott DM, Atun R, Moyes C.L., Hay SI, Gething PW Funding for malaria control 2006-2010: a comprehensive global assessment. Malar J 2012; 11: 246.
3. Korenromp EL, Hosseini M, Newman R.D., Cibulskis RE Progress towards malaria control targets in relation to national malaria programme funding. Malar J 2013; 12: 18.
4. Feachem RG, Phillips AA, Hwang J, et al Shrinking the malaria map: progress and prospects. Lancet 2010; 376: 1566-78.
5. Chizema-Kawesha E., Miller JM, Steketee R.W., et al. Scaling up malaria control in Zambia: progress and impact 2005-2008. Am J Trop Med Hyg 2010; 83: 480-88.
6. Moonasar D, Nutulaganti T, Kruger P.S., et al. Malaria control in South Africa 2000-2010: beyond MDG6. Malar J 2012; 11: 294.
7. Sharp BL, Kleinschmidt I, Streat E., et al. Seven years of regional malaria control collaboration-Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg 2007; 76: 42-47.
8. Pan American Health Organization. Report on the situation of malaria in the Americas. Washington: Pan American Health Organization, Regional Office of the World Health Organization, 2010. http://www2.paho.org/hq/dmdocuments/2011/ PAHO-ENG-Malaria-LR.pdf (accessed Sept 18, 2012).
9. Mendis K, Rietveld A, Warsame M., Bosman A, Greenwood B, Wernsdorfer WH From malaria control to eradication: the WHO perspective. Trop Med Int Health 2009; 14: 802-09.
10. Yangzom T, Smith Gueye C, Namgay R, et al Malaria control in Bhutan: case study of a country embarking on elimination. Malar J 2012; 11: 9.
11. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One 2012; 7: e43162.
12. Roll Back Malaria Partnership. Defeating malaria in Asia, the Pacific, Americas, Middle East and Europe. Geneva: World Health Organization, 2012.
13. Baird JK. Eliminating malaria-all of them. Lancet 2010; 376: 1883-85.
14. Das P, Horton R. Malaria elimination: worthy, challenging, and just possible. Lancet 2010; 376: 1515-17.
15. Marsh K. Research priorities for malaria elimination. Lancet 2010; 376: 1626-27.
16. Moonen B, Cohen JM, Snow R.W., et al. Operational strategies to achieve and maintain malaria elimination. Lancet 2010; 376: 1592-603.
17. Sabot O, Cohen JM, Hsiang M.S., et al. Costs and financial feasibility of malaria elimination. Lancet 2010; 376: 1604-15.
18. Tatem AJ, Smith DL, Gething P.W., Kabaria CW, Snow RW, Hay SI Ranking of elimination feasibility between malaria-endemic countries. Lancet 2010; 376: 1579-91.
19. World Development Indicators. World Bank, 2012. http://data.worldbank. org/ (accessed Oct 8, 2012).
20. Chiyaka C, Tatem AJ, Cohen M.J., et al. Infectious disease. The stability of malaria elimination. Science 2013; 339: 909-10.
21. Dondorp AM, Nosten F, Yi P., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-67.
22. WHO. WHO hails political leaders' support for malaria plan. Published online Nov 23, 2012. http://www.wpro.who.int/mediacentre/releases/2012/20121123/ en/index.html (accessed Dec 20, 2012).
23. Bousema T, Griffin JT, Sauerwein RW, et al. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med 2012; 9: e1001165.
24. Chuquiyauri R, Paredes M, Penataro P., et al. Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop 2011; 121: 292-302.
25. Lansang MA, Belizario VY, Bustos M.D., Saul A., Aguirre A. Risk factors for infection with malaria in a low endemic community in Bataan, the Philippines. Acta Trop 1997; 63: 257-65.
26. Ngomane L, de Jager C. Changes in malaria morbidity and mortality in Mpumalanga Province, South Africa (2001-2009): a retrospective study. Malar J 2012; 11: 19.
27. Incardona S, Vong S, Chiv L., et al. Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors. Malar J 2007; 6: 37.
28. Camargo LM, Ferreira MU, Krieger H, De Camargo EP, Da Silva LP. Unstable hypoendemic malaria in Rondonia (western Amazon region, Brazil): epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement. Am J Trop Med Hyg 1994; 51: 16-25.
29. Erhart A, Ngo DT, Phan V.K., et al. Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malar J 2005; 4: 58.
30. Bhumiratana A, Sorosjinda-Nunthawarasilp P, Kaewwaen W., Maneekan P, Pimnon S. Malaria-associated rubber plantations in Thailand. Travel Med Infect Dis 2012; 11: 37-50.
31. Harris I, Sharrock WW, Bain L.M., et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J 2010; 9: 254.
32. Kleinschmidt I, Sharp B. Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity. Trop Med Int Health 2001; 6: 986-91.
33. Vinetz JM, Gilman RH Asymptomatic Plasmodium parasitemia and the ecology of malaria transmission. Am J Trop Med Hyg 2002; 66: 639-40.
34. Vector Borne Disease Control Program: Sabah State Malaysia. Malaria information system database query, 2012. Ministry of Health, Sabah State, Malaysia.
35. Ministry of Health Sri Lanka, WHO, Global Health Group University of California, San Francisco. Eliminating malaria: case-study 3. Progress towards elimination in Sri Lanka. Geneva: World Health Organization, 2012.
36. Trung HD, Bortel WV, Sochantha T, Keokenchanh K., Briet OJ, Coosemans M. Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control. Trop Med Int Health 2005; 10: 251-62.
37. Tobgay T, Torres CE, Na-Bangchang K. Malaria prevention and control in Bhutan: successes and challenges. Acta Trop 2010; 117: 225-28.
38. Wangdi K, Kaewkungwal J, Singhasivanon P., Silawan T, Lawpoolsri S, White NJ Spatiotemporal patterns of malaria infection in Bhutan: a country embarking on malaria elimination. Malar J 2011; 10: 89.
39. Chai JY. Re-emerging Plasmodium vivax malaria in the Republic of Korea. Korean J Parasitol 1999; 37: 129-43.
40. Mae Sot, IRIN, UN Office for the Coordination of Humanitarian Affairs. Myanmar-Thailand: struggling against malaria in conflict settings. May 4, 2012. http://www.irinnews.org/Report/95402/MYANMAR-THAILAND-Struggling-against- malaria-in-conflict-areas (accessed Sept 19, 2012).
41. Hiwat H, Hardjopawiro LS, Takken W, Villegas L. Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J 2012; 11: 10.
42. Gerritsen AA, Kruger P, van der Loeff MF, Grobusch MP. Malaria incidence in Limpopo Province, South Africa, 1998-2007. Malar J 2008; 7: 162.
43. Prothero RM. Malaria in Latin America: environmental and human factors. Bull Latin Am Res 1995; 14: 357-65.
44. Martens P, Hall L. Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis 2000; 6: 103-09.
45. Amarasinghe SW. A socio-economic study of small-scale gemstone mining in Sri Lanka (draft). Sri Lanka: UK Department for International Development (DFID), 1999. http://practicalaction.org/docs/consulting/miners%20socio- economic%20study%20-%20sri%20lanka%20-%20draft.pdf (accessed Aug 30, 2012).
46. Packard RM. Agricultural development, migrant labor and the resurgence of malaria in Swaziland. Soc Sci Med 1986; 22: 861-67.
47. Feachem RGA, and the Malaria Elimination Group. Shrinking the malaria map: a guide on malaria elimination for policy makers. San Francisco: The Global Health Group, Global Health Sciences, University of California, San Francisco, 2009.
48. Mohammed Hassan Al-Zahrani. Updates on malaria elimination in the Kingdom of Saudi Arabia. Presented at the Seventh Malaria Elimination Group meeting, 2012; Al Ain, United Arab Emirates: The Global Health Group at the University of California, San Francisco. http://www.malariaeliminationgroup.org/about/ meg%20meetings/meg-vii-meeting (accessed Dec 20, 2012).
49. WHO. Informal consultation on malaria elimination: setting up the WHO agenda. Geneva: World Health Organization, 2006.
50. Cohen JM, Smith DL, Cotter C, et al Malaria resurgence: a systematic review and assessment of its causes. Malar J 2012; 11: 122.
51. Andriopoulos P, Economopoulou A, Spanakos G., Assimakopoulos G. A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece - a re-emerging infection in the southern borders of Europe? Int J Infect Dis 2013; 17: e125-28.
52. Craig MH, Kleinschmidt I, Le Sueur D, Sharp BL Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: part II. The impact of non-climatic factors. Trop Med Int Health 2004; 9: 1258-66.
53. Sevilla-Casas E. Human mobility and malaria risk in the Naya river basin of Colombia. Soc Sci Med 1993; 37: 1155-67.
54. Zhou HY, Wang WM, Cao J, Zhu G.D., Gao Q. Epidemiological analysis of malaria situation in Jiangsu Province in 2009. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2011; 23: 402-05.
55. Pilipinas Shell Foundation. Round 2 Proposal: advancing malaria control towards elimination by 2020. Philippines: The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2002. http://portfolio.theglobalfund.org/en/Grant/ Index/PHL-202-G09-M (accessed Aug 28, 2012).
56. Vector Borne Disease Control Program (VBDCP), Ministry of Health, Solomon Islands. National Malaria Strategic Vision 2007-2016: Solomon Islands. http://apmen.org/storage/country-partner/Solomon%20Islands%20- %20National%20Vision%20Statement.pdf (accessed Sept 19, 2012).
57. Vector Borne Disease Control Program (VBDCP), Ministry of Health, Vanuatu. National Malaria Strategic Vision 2007-2016: Vanuatu. http://apmen.org/storage/country-partner/Vanuatu%20- %20National%20Vision%20Statement.pdf (accessed Sept 19, 2012).
58. Tatarsky A, Aboobakar S, Cohen J.M., et al. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One 2011; 6: e23832.
59. Gething PW, Elyazar IR, Moyes C.L., et al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 2012; 6: e1814.
60. Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev 2013; 26: 36-57.
61. Price RN, Tjitra E, Guerra C.A., Yeung S., White NJ, Anstey NM Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007; 77: 79-87.
62. WHO. Global malaria control and elimination: report of a technical review. Geneva: World Health Organization, 2008. http://www.who.int/malaria/ publications/atoz/9789241596756/en/index.html (accessed July 15, 2012).
63. Vector Borne Disease Control Program: Solomon Islands. Solomon Islands Vector Borne Disease Control Program. Malaria information system database query, 2012. Ministry of Health, Solomon Islands.
64. Mueller I, Galinski MR, Baird J.K., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009; 9: 555-66.
65. Collins WE, Jeffery GM, Roberts JM A retrospective examination of re-infection of humans with Plasmodium vivax. Am J Trop Med Hyg 2004; 70: 642-44.
66. John GK, Douglas NM, von Seidlein L, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J 2012; 11: 280.
67. Oguike MC, Betson M, Burke M., et al. Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities. Int J Parasitol 2011; 41: 677-83.
68. Steenkeste N, Rogers WO, Okell L, et al Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J 2010; 9: 108.
69. Baltzell KA, Shakely D, Hsiang M., et al. Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg 2013; 88: 289-91.
70. Rajahram GS, Barber BE, William T, Menon J., Anstey NM, Yeo TW Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate. Malar J 2012; 11: 284.
71. Baird JK. Malaria zoonoses. Travel Med Infect Dis 2009; 7: 269-77.
72. Cox-Singh J., Davis TM, Lee K.S., et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008; 46: 165-71.
73. Cox-Singh J., Singh B. Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol 2008; 24: 406-10.
74. Barber BE, William T, Grigg M.J., et al. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis 2013; 56: 383-97.
75. Alves FP, Durlacher RR, Menezes M.J., Krieger H., Silva LH, Camargo EP High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002; 66: 641-48.
76. Pinto J, Sousa CA, Gil V, et al Malaria in Säo Tomé and Príncipe: parasite prevalences and vector densities. Acta Trop 2000; 76: 185-93.
77. Owusu-Agyei S., Smith T, Beck H.P., Amenga-Etego L, Felger I. Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health 2002; 7: 421-28.
78. Bousema JT, Gouagna LC, Drakeley C.J., et al. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 2004; 3: 18.
79. Okell LC, Ghani AC, Lyons E, Drakeley CJ Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis 2009; 200: 1509-17.
80. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 2012; 3: 1237.
81. Cohen JM, Moonen B, Snow R.W., Smith DL How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J 2010; 9: 213.
82. Barclay VC, Smith RA, Findeis JL Surveillance considerations for malaria elimination. Malar J 2012; 11: 304.
83. Kelly GC, Tanner M, Vallely A., Clements A. Malaria elimination: moving forward with spatial decision support systems. Trends Parasitol 2012; 28: 297-304.
84. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop 2010; 114: 177-83.
85. Ruebush TK 2nd, Godoy HA. Community participation in malaria surveillance and treatment. I. The Volunteer Collaborator Network of Guatemala. Am J Trop Med Hyg 1992; 46: 248-60.
86. Kazembe LN. Spatial modelling and risk factors of malaria incidence in northern Malawi. Acta Trop 2007; 102: 126-37.
87. Zacarias OP, Andersson M. Mapping malaria incidence distribution that accounts for environmental factors in Maputo Province-Mozambique. Malar J 2010; 9: 79.
88. Macauley C. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med 2005; 60: 563-73.
89. WHO. Disease surveillance for malaria elimination: an operational manual. Geneva: World Health Organization, 2012.
90. Qi G. '1,3,7' new malaria elimination strategy and implementation in China. Presented at the Seventh Malaria Elimination Group meeting, 2012; Al Ain, United Arab Emirates: Malaria Elimination Group. http://www. malariaeliminationgroup.org/about/meg%20meetings/meg-vii-meeting (accessed Dec 20, 2012).
91. Sanders K, Smith Gueye C, Phillips AA, Gosling R. Active case detection for malaria elimination: a confusion of acronyms and definitions. Malaria Chemotherapy, Control Elim 2012; 1: 235-552.
92. Sutcliffe CG, Kobayashi T., Hamapumbu H, et al. Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One 2012; 7: e31396.
93. Sturrock HJW, Bousema JT, Mosha J, Gosling RD Finding hotspots: the role of active surveillance methods in malaria control and elimination. Malar J 2012; 11 (suppl 1): O6.
94. Cordray MS, Richards-Kortum RR. Emerging nucleic acid-based tests for point-of-care detection of malaria. Am J Trop Med Hyg 2012; 87: 223-30.
95. Congpuong K, Saejeng A, Sug-Aram R, et al. Mass blood survey for malaria: pooling and realtime PCR combined with expert microscopy in north-west Thailand. Malar J 2012; 11: 288.
96. Hsiang MS, Hwang J, Kunene S., et al. Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One 2012; 7: e29550.
97. Remoue F, Cisse B, Ba F., et al. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop Med Hyg 2006; 100: 363-70.
98. Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther 2009; 85: 659-64.
99. von Seidlein L., Greenwood BM Mass administrations of antimalarial drugs. Trends Parasitol 2003; 19: 452-60.
100. Bruce-Chwatt LJ. Malaria research and eradication in the USSR: a review of Soviet achievements in the field of malariology. Bull World Health Organ 1960; 21: 737-72.
101. Gosling RD, Okell L, Mosha J., Chandramohan D. The role of antimalarial treatment in the elimination of malaria. Clin Microbiol Infect 2011; 17: 1617-23.
102. Okell LC, Griffin JT, Kleinschmidt I, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One 2011; 6: e20179.
103. Katz TM, Miller JH, Hebert AA Insect repellents: historical perspectives and new developments. J Am Acad Dermatol 2008; 58: 865-71.
104. Curtis CF, Wilkes TJ, Mbwana H, Chambika C., Aina Y. Comparison of the effectiveness and persistence of mosquito repellency due to Quwenling and DEET. Trans R Soc Trop Med Hyg 1994; 88: 371-72.
105. Vittal M & Limaye LS. Field village scale trial of use of repellent in malaria control. Indian J Med Sci 1984; 38: 201-03.
106. Rowland M, Downey G, Rab A., et al. DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan. Trop Med Int Health 2004; 9: 335-42.
107. Hill N, Lenglet A, Arnez A.M., Carneiro I. Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon. BMJ 2007; 335: 1023.
108. Thang ND, Erhart A, Speybroeck N., et al. Long-lasting insecticidal hammocks for controlling forest malaria: a community-based trial in a rural area of central Vietnam. PLoS One 2009; 4: e7369.
109. Rowland M, Durrani N, Hewitt S., et al. Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies. Trans R Soc Trop Med Hyg 1999; 93: 465-72.
110. Kimani EW, Vulule JM, Kuria I.W., Mugisha F. Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar J 2006; 5: 63.
111. Specos MM, Garcia JJ, Tornesello J, et al Microencapsulated citronella oil for mosquito repellent finishing of cotton textiles. Trans R Soc Trop Med Hyg 2010; 104: 653-58.
112. Cousens SN, Mertens TE, Kirkwood B.R., Smith PG, Feachem RGA. Case-control studies of common childhood diseases: the example of diarrhoea. London: Macmillan Education, 1995.
113. Davaalkham J, Unenchimeg P, Baigalmaa C., et al. Identification of a current hot spot of HIV type 1 transmission in Mongolia by molecular epidemiological analysis. AIDS Res Hum Retroviruses 2011; 27: 1073-80.
114. Small PM, Hopewell PC, Singh S.P., et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-09.
115. Sun SJ, Bennett DE, Flood J, Loeffler AM, Kammerer S, Ellis BA Identifying the sources of tuberculosis in young children: a multistate investigation. Emerg Infect Dis 2002; 8: 1216-23.
116. Daniels R, Volkman SK, Milner D.A., et al. A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking. Malar J 2008; 7: 223.
117. Gandhi K, Thera MA, Coulibaly D, et al Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg 2012; 86: 775-81.
118. Manske M, Miotto O, Campino S., et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 2012; 487: 375-79.
119. Koepfli C., Mueller I, Marfurt J., et al. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis 2009; 199: 1074-80.
120. Schultz L, Wapling J, Mueller I., et al. Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J 2010; 9: 336.
121. Heimer R, Clair S, Grau L.E., Bluthenthal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction 2002; 97: 1277-87.
122. Johnston LG, Sabin K, Mai T.H., Pham TH Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: reaching the unseen sex worker. J Urban Health 2006; 83 (SUPPL. 1): 16-28.
123. Magnani R, Sabin K, Saidel T., Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005; 19 (SUPPL. 2): S67-72.
124. Mantecon A, Juan M, Calafat A., Becona E, Roman E. Respondent-driven sampling: a new sampling method to study visible and hidden populations. Adicciones 2008; 20: 161-69.
125. Khamsiriwatchara A, Wangroongsarb P, Thwing J., et al. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers? Malar J 2011; 10: 120.
126. Cai WD, Zhao J, Zhao J.K., et al. HIV prevalence and related risk factors among male sex workers in Shenzhen, China: results from a time-location sampling survey. Sex Transm Infect 2009; 86: 15-20.
127. Humphreys M. Malaria: poverty, race and public health in the United States. Baltimore: Johns Hopkins University Press, 2001.
128. Lindsay SW, Emerson PM, Charlwood JD Reducing malaria by mosquito-proofing houses. Trends Parasitol 2002; 18: 510-14.
129. Lindsay SW, Jawara M, Paine K., Pinder M, Walraven GE, Emerson PM Changes in house design reduce exposure to malaria mosquitoes. Trop Med Int Health 2003; 8: 512-17.
130. Atieli H, Menya D, Githeko A., Scott T. House design modifications reduce indoor resting malaria vector densities in rice irrigation scheme area in western Kenya. Malar J 2009; 8: 108.
131. Ogoma SB, Lweitoijera DW, Ngonyani H, et al Screening mosquito house entry points as a potential method for integrated control of endophagic filariasis, arbovirus and malaria vectors. PLoS Negl Trop Dis 2010; 4: e773.
132. Malaria Vaccine Initiative. Press release, June 2, 1999, Seattle, USA. www.malariavaccine.org/files/1999Jan3-BMGFGrantaward-PR.pdf (accessed Sept 20, 2012).
133. Agnandji S.T., Lell B, Soulanoudjingar S.S., et al. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N Engl J Med 2011; 365: 1863-75.
134. Vannice KS, Brown GV, Akanmori B.D., Moorthy VS MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines. Malar J 2012; 11: 372.
135. Feachem RGA, Phillips AA, Targett G.A., eds. Shrinking the malaria map: a prospectus on malaria elimination. San Francisco: The Global Health Group, Global Health Sciences, University of California, San Francisco, 2009.
136. The Elimination Eight (E8) Regional Initiative: paving the way for malaria elimination in southern Africa. Global Health Group at the University of California, San Francisco, 2012. http://www.malariaeliminationgroup.org/sites/ default/files/E8%20Overview%20Final.pdf (accessed Oct 15, 2012).
137. Gosling RD, Whittaker M, Smith Gueye C, et al. Malaria elimination gaining ground in the Asia Pacific. Malar J 2012; 11: 346.
138. Bureau of Vector Borne Disease. National strategic plan for malaria control and elimination in Thailand: 2011-2016. Thailand: Department of Disease Control, Ministry of Public Health, 2010.
139. Chinese Center for Disease Control and Prevention. Round 6 Proposal: malaria control across China-Myanmar borderline areas. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2006.
140. National Program for Control of Tropical Diseases (CENCET). Round 8 proposal: Strengthen the fight against malaria in vulnerable populations of municipalities with high incidence in the Dominican Republic. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria, 2008.
141. Atta H, Zamani G. The progress of Roll Back Malaria in the eastern Mediterranean region over the past decade. East Mediterr Health J 2008; 14 (SUPPL): S82-89.
142. Nunuhe M. Namibia, Angola sign cross-border malaria pact. Published online April 27, 2011. http://www.newera.com.na/article.php?articleid=38467 (accessed Aug 10, 2012).
143. O'Sullivan M., Kenilorea G, Yamaguchi Y., et al. Malaria elimination in Isabel Province, Solomon Islands: establishing a surveillance-response system to prevent introduction and reintroduction of malaria. Malar J 2011; 10: 235.
144. Kanapathy V. Controlling irregular migration: the Malaysian experience (draft). Presented at the Regional Symposium on Managing Labour Migration in East Asia May 16-18, 2007. Singapore: Institute of Strategic and International Studies (Malaysia), 2007.
145. Smith Gueye C., Teng A, Kinyua K., Wafula F, Gosling R, McCoy D. Parasites and vectors carry no passport: how to fund cross-border and regional efforts to achieve malaria elimination. Malar J 2012; 11: 344.